Unnati Pharmax

ACIVIR 500mg Injection
Composition: Acyclovir Intravenous Infusion IP 500mg
International Trade Name: Zovirax®

ACIVIR 500mg is a high-quality Acyclovir intravenous infusion, an antiviral medication used for the treatment of severe viral infections caused by herpes simplex virus (HSV) and varicella-zoster virus (VZV). Manufactured in WHO-GMP certified facilities, ACIVIR Injection is supplied by trusted pharmaceutical exporters from India to support global infectious disease and hospital care programs.

Acyclovir works by inhibiting viral DNA synthesis, thereby preventing viral replication and limiting the spread of infection. Its selective action against infected cells helps reduce the severity and duration of viral outbreaks while minimizing damage to healthy tissues.

ACIVIR 500mg Injection is primarily indicated for the treatment of severe herpes simplex infections, genital herpes, herpes encephalitis, neonatal herpes, and varicella-zoster infections, particularly in immunocompromised patients. It is suitable for adult and pediatric patients under strict medical supervision in hospital and critical care settings.

ACIVIR 500mg Acyclovir Intravenous Infusion IP is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The injection is supplied in secure, tamper-proof, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, infectious disease units, tertiary care centers, and international pharmaceutical distributors.

Chirorab Injection
Composition: Purified Rabies Vaccine (Inactivated) for Intramuscular/Intracutaneous Use
International Trade Name: Chirorab®

Chirorab is a high-quality inactivated rabies vaccine formulated for the prevention of rabies, a fatal viral zoonotic disease transmitted through the bite or scratch of infected animals. Manufactured in WHO-GMP certified facilities, Chirorab Vaccine is supplied by trusted pharmaceutical exporters from India to support global immunization and public health programs.

The vaccine works by stimulating the body’s immune system to produce protective antibodies against the rabies virus. This active immunization helps prevent infection when administered as pre-exposure prophylaxis or post-exposure prophylaxis following potential rabies exposure.

Chirorab is primarily indicated for pre-exposure immunization in high-risk individuals such as veterinarians, animal handlers, laboratory personnel, and travelers to rabies-endemic areas. It is also used for post-exposure prophylaxis in individuals bitten or scratched by suspected rabid animals, in combination with rabies immunoglobulin when required.

Chirorab Rabies Vaccine is manufactured under stringent GMP and biological quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The vaccine is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, government vaccination programs, travel clinics, public health institutions, and international pharmaceutical distributors.

ACIVIR 250mg Injection
Composition: Aciclovir 250mg for Intravenous Infusion IP
International Trade Name: Zovirax®

ACIVIR 250mg Injection is a high-quality antiviral formulation containing Aciclovir, a potent nucleoside analogue effective against a wide range of herpes virus infections. Manufactured in WHO-GMP certified facilities, ACIVIR Injection is supplied by trusted pharmaceutical exporters from India to support global infectious disease treatment programs.

Aciclovir works by inhibiting viral DNA synthesis, thereby preventing the replication of herpes viruses such as Herpes simplex virus (HSV) types 1 and 2, and Varicella-zoster virus (VZV). Its selective mechanism of action ensures effective viral suppression with minimal impact on healthy host cells.

ACIVIR 250mg Injection is primarily indicated for the treatment of severe herpes simplex infections, herpes encephalitis, neonatal herpes, and serious varicella-zoster infections, particularly in immunocompromised patients. It is also used for prophylaxis in high-risk patients undergoing organ transplantation or chemotherapy.

ACIVIR 250mg Aciclovir Intravenous Infusion is manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent efficacy, safety, sterility, and long-term stability. The injection is supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, intensive care units, infectious disease centers, and international pharmaceutical distributors.

XYOTIN 100mg Injection
Composition: Bendamustine Hydrochloride for Injection 100mg
International Trade Name: Treanda® / Bendeka®

XYOTIN 100mg is a high-quality Bendamustine Hydrochloride injection, an alkylating antineoplastic agent used in the treatment of various hematological malignancies. Manufactured in WHO-GMP certified facilities, XYOTIN Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs.

Bendamustine exhibits a unique dual mechanism of action, combining properties of alkylating agents and purine analogs. It causes cross-linking of DNA strands, leading to disruption of DNA synthesis and apoptosis of cancer cells. This distinct pharmacological profile contributes to its effectiveness in resistant and relapsed malignancies.

XYOTIN 100mg Injection is primarily indicated for the treatment of chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), and indolent B-cell malignancies. It is commonly used in patients who have progressed on or are refractory to standard therapies.

XYOTIN 100mg Bendamustine Injection is manufactured under stringent GMP and oncology-grade quality standards, ensuring consistent potency, sterility, safety, and long-term stability. The injection is supplied in secure, tamper-proof, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.